Title : A nonsynonymous variation in MRP2/ABCC2 is associated with neurological adverse drug reactions of carbamazepine in patients with epilepsy.

Pub. Date : 2010 Apr

PMID : 20216337






7 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A nonsynonymous variation in MRP2/ABCC2 is associated with neurological adverse drug reactions of carbamazepine in patients with epilepsy. Carbamazepine ATP binding cassette subfamily C member 2 Homo sapiens
2 A nonsynonymous variation in MRP2/ABCC2 is associated with neurological adverse drug reactions of carbamazepine in patients with epilepsy. Carbamazepine ATP binding cassette subfamily C member 2 Homo sapiens
3 Therefore, genetic variations in the MRP2 gene may affect individual drug responses to the antiepileptic agent carbamazepine. Carbamazepine ATP binding cassette subfamily C member 2 Homo sapiens
4 METHODS: Associations between MRP2 polymorphisms and the adverse drug reactions (ADRs) of carbamazepine were analyzed using an integrated population genetics and molecular functional approach. Carbamazepine ATP binding cassette subfamily C member 2 Homo sapiens
5 Logistic regression analysis with multiple clinical variables indicated that the presence of A allele at the MRP2 c.1249G>A locus was an independent determinant of central nervous system ADR caused by carbamazepine. Carbamazepine ATP binding cassette subfamily C member 2 Homo sapiens
6 The functional study using ATPase assay and FACScan flow cytometer indicated that carbamazepine was a substrate of MRP2 and that the 417I variation selectively reduced carbamazepine transport across the cell membrane. Carbamazepine ATP binding cassette subfamily C member 2 Homo sapiens
7 CONCLUSION: These results strongly suggest that the A-allele of the MRP2 single nucleotide polymorphism c.1247G>A is associated with adverse neurological drug reactions to carbamazepine. Carbamazepine ATP binding cassette subfamily C member 2 Homo sapiens